First Time Loading...

FibroGen Inc
NASDAQ:FGEN

Watchlist Manager
FibroGen Inc Logo
FibroGen Inc
NASDAQ:FGEN
Watchlist
Price: 1.125 USD -0.44% Market Closed
Updated: May 4, 2024

FibroGen Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

FibroGen Inc
Cash from Financing Activities Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
FibroGen Inc
NASDAQ:FGEN
Cash from Financing Activities
$122.7m
CAGR 3-Years
110%
CAGR 5-Years
55%
CAGR 10-Years
68%
Abbvie Inc
NYSE:ABBV
Cash from Financing Activities
-$17.2B
CAGR 3-Years
-14%
CAGR 5-Years
-4%
CAGR 10-Years
-17%
Gilead Sciences Inc
NASDAQ:GILD
Cash from Financing Activities
-$5.1B
CAGR 3-Years
N/A
CAGR 5-Years
9%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Cash from Financing Activities
$21B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
23%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Cash from Financing Activities
-$562.2m
CAGR 3-Years
-4%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Cash from Financing Activities
-$1.8B
CAGR 3-Years
3%
CAGR 5-Years
-88%
CAGR 10-Years
N/A

See Also

What is FibroGen Inc's Cash from Financing Activities?
Cash from Financing Activities
122.7m USD

Based on the financial report for Dec 31, 2023, FibroGen Inc's Cash from Financing Activities amounts to 122.7m USD.

What is FibroGen Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
68%

Over the last year, the Cash from Financing Activities growth was 162%. The average annual Cash from Financing Activities growth rates for FibroGen Inc have been 110% over the past three years , 55% over the past five years , and 68% over the past ten years .